AngioDynamics this week announced it received FDA 510(k) clearance for its AlphaVac F18 system to treat pulmonary embolism (PE). The expanded FDA indication allows for the use of AlphaVac F18 system for the treatment of PE. The new indication expands the device’s use in the non-surgical removal of thrombi or emboli from the venous vasculature. […]
Cardiovascular
Welcome to MassDevice's Cardiovascular Hub, your resource for the latest news in cardiac implants, structural heart, heart valves, stents and more. Stay informed about the innovations and business news shaping the cardiovascular device industry.
🫀 Narrow your focus with these categories:
Cardiac Implants | Structural Heart | Pulsed-Field Ablation
Here are top cardiology features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ LVADs save lives: So why aren’t more available?
+ How Medtronic uses nitinol to improve the structure and effectiveness of heart devices
+ How Abbott designed the world’s first dual-chamber leadless pacemaker system
+ J&J used RWE for expanded indications — and you can, too
+ 7 cardiology startups you need to know
Latest Cardiology News
Johnson & Johnson to acquire Shockwave Medical for $13.1B
Johnson & Johnson announced today that it agreed to acquire Shockwave Medical (Nasdaq:SWAV) for approximately $13.1 billion. Media reports previously linked Johnson & Johnson with interest in buying the intravascular lithotripsy (IVL) technology maker last year. Suggestions of interest in a deal resurfaced just weeks ago and now the companies have reached an agreement. Under […]
Silk Road launches next-gen transcarotid neuroprotection system
Silk Road Medical (Nasdaq:SILK) announced that it launched its EnRoute Plus transcarotid neuroprotection system. The transcarotid artery revascularization (TCAR) system builds upon the company’s previous EnRoute system, launched just last month. It delivers smoother arterial sheath insertion, greater flow precision and a simplified prep experience for surgical teams. The system delivers all this while maintaining […]
FDA clears Eko Health’s AI for heart failure detection
Eko Health announced today that the FDA cleared its Low EF (ejection fraction) detection AI platform for its digital stethoscope. Using an Eko stethoscope, providers can now detect Low EF — a heart failure indicator — in 15 seconds during a routine physical exam. Low EF AI embeds rapid, accessible low EF detection into a […]
FDA approves Abbott TriClip TEER system
Abbott announced today that the FDA granted approval for its first-of-ts-kind TriClip transcatheter edge-to-edge repair (TEER) system. The expected approval comes after a February vote by an FDA panel that confirmed the system’s benefits outweighed its risks. Abbott designed TriClip to treat tricuspid regurgitation (TR), or a leaky tricuspid valve. Delivered through a vein in […]
Haemonetics completes Attune Medical acquisition
Haemonetics announced today that it completed its previously announced acquisition of Attune Medical. Boston-based Haemonetics agreed to buy Attune for an upfront cash payment of $160 million just under a month ago. Chicago-based Attune medical develops the ensoETM proactive esophageal cooling device. The company designed ensoETM to reduce the likelihood of ablation-related esophageal injury. These […]
Pulse Biosciences to raise $60M
Pulse Biosciences (Nasdaq:PLSE) announced that its board of directors approved plans to initiate a rights offering worth $60 million. The offering features up to $60 million in the form of “units” available to all holders of the company’s common stock. Each unit consists of one share of common stock and warrants to purchase a total […]
JenaValve publishes positive data for its TAVR system
JenaValve announced today that it published new results supporting the use of its transcatheter aortic valve replacement (TAVR) system. The company published results from its ALIGN-AR pivotal trial in The Lancet. The trial evaluates the Trilogy valve in high-risk patients with symptomatic moderate-to-severe or severe aortic regurgitation. JenaValve presented positive study results from ALIGN-AR last […]
FDA approves next-gen Evolut TAVR system from Medtronic
Medtronic announced today that the FDA approved its next-generation Evolut FX+ transcatheter aortic valve replacement (TAVR) system. The FDA’s approval covers the treatment of symptomatic aortic stenosis. Medtronic says the latest version of the Evolut valve maintains the performance of the Evolut platform with a design that facilitates coronary access. Evolut FX+ TAVR offers larger […]
Edwards Lifesciences’ chair Michael Mussallem retires from board
Edwards Lifesciences announced that Chair Michael Mussallem is retiring from the board of directors a year after stepping down as CEO. Mussallem became a non-executive chair of the Irvine, California-based company after he retired from his CEO post on May 11, 2023. He is expected to be succeeded by independent director Nicholas Valeriani, who will […]
Shockwave Medical is reportedly a J&J acquisition target
Shockwave Medical could get acquired by Johnson & Johnson , according to a Wall Street Journal report. WSJ cited people familiar with the matter. They said the acquisition talks, if successful, could result in a finalized deal in the coming weeks. Another suitor could also seek a merger with Santa Clara, California–based Shockwave. The WSJ […]